Impact of initial dialysis modality on the survival of patients with ESRD: a propensity-score-matched study

Author:

Liu Li,Pang Jie,Xu Juan,Liu Lin-na,Liao Man-yu,Huang Qing-xiu,Li Yan-lin

Abstract

Abstract Background Studies comparing the survival of hemodialysis (HD) and peritoneal dialysis (PD) patients are controversial. This study evaluated the impact of initial dialysis modality on the survival of patients with end-stage renal disease (ESRD) in a matched-pair cohort. Methods A retrospective cohort study was performed on ESRD patients who initiated renal replacement treatment between January 1, 2010, and December 31, 2018. Propensity score matching was applied to balance the baseline conditions, and multivariate Cox regression analysis was applied to compare mortality between HD and PD patients and evaluate correlations between mortality and various baseline characteristics. Subgroup analysis was performed with respect to diabetes status. Results There were 739 patients in our center in the Chinese National Renal Data System (CNRDS) between 2010 and 2018. Of these, 125 PD patients were matched with 125 HD patients. The 1-, 2-, and 3-year survival rates were 96.5%, 90.7%, and 82.5%, respectively, in the HD group and 99.5%, 97.8%, and 92.5%, respectively, in the PD group (log-rank P < 0.001). Among the propensity score-matched cohorts, no significant differences in Kaplan–Meier curves were observed between the two groups (log-rank P = 0.514). Age at dialysis initiation, CCI, congestive heart failure and cerebrovascular disease were risk factors in the multivariable-adjusted model. In subgroups defined by diabetes status, the Kaplan‒Meier survival curve showed that PD survival was significantly higher than that of HD (log-rank P = 0.022). Conclusions HD and PD were not significantly different regarding the survival of patients with ESRD. PD was associated with better survival in diabetic ESRD patients.

Funder

Research project of Zhongshan Health Bureau

the Foundation of National Key Clinical Department (Traditional Chinese Medicine), China

the Project of Guangdong Provincial Famous Traditional Chinese Medicine Studio

the Research Fund of Guangdong Provincial Administration of Traditional Chinese Medicine

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Reference35 articles.

1. Thurlow JS, et al. Global epidemiology of end-stage kidney disease and disparities in kidney replacement therapy. Am J Nephrol. 2021;52(2):98–107.

2. Chen JY, et al. The Health-Related quality of life of chinese patients on Hemodialysis and Peritoneal Dialysis. The Patient. 2017;10(6):799–808.

3. Korevaar JC, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int. 2003;64(6):2222–8.

4. Wong B, et al. Comparison of patient survival between Hemodialysis and Peritoneal Dialysis among Patients Eligible for both modalities. Am J Kidney Dis. 2018;71(3):344–51.

5. Beladi Mousavi SS, et al. Comparison of survival in patients with end-stage renal disease receiving hemodialysis versus peritoneal dialysis. Saudi journal of kidney diseases and transplantation: an official publication of the Saudi Center for Organ Transplantation. Saudi Arabia. 2015;26(2):392–7.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3